EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Evaluation of Azithromycin-Loaded Transethosomes for Enhanced Dermal Delivery and Antibacterial Efficacy

Meriem Rezigue, Hadeia Mashaqbeh iD, Alaa A A Aljabali iD, Randa Sh Mansour, Iyad Hamzeh

Pharmaceutics · 21.03.2025 · 17 (4) · 400

DOI: 10.3390/pharmaceutics17040400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 21.03.2025. Verfasst von Meriem Rezigue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research and Postgraduate Studies at Yarmouk University, Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The topical delivery of antibiotics through transethosomes shows promise for enhancing its dermal delivery for the treatment of skin infections. This study aimed to develop and characterize azithromycin-loaded transethosomes to enhance topical drug delivery and improve the antibacterial activity of azithromycin.

Methods

The prepared azithromycin formulations underwent assessment for various characteristics, including their vesicle dimensions, size distribution, zeta potential, encapsulation efficiency, and morphological features (via TEM analysis). Additionally, their thermal properties were examined through DSC analysis, and their stability was monitored over six months under refrigerated storage conditions. The sequential tape-stripping technique was employed to conduct ex vivo penetration studies on human skin. Interactions between transethosomes and stratum corneum lipids were examined using attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR). Additionally, the formulations were tested for their in vitro antibacterial efficacy against Staphylococcus aureus.

Results

The findings revealed that AZ 1 and AZ 2 had vesicle sizes of 108.44 ± 5.72 nm and 70.42 ± 6.02 nm, zeta potential measurements of −11.897 ± 1.820 mV and −34.575 ± 4.535 mV, and high entrapment efficiencies of 99.259 ± 0.086% and 99.560 ± 0.014%, respectively. Transmission electron microscopy (TEM) analysis confirmed the spherical nature of the vesicles, whereas differential scanning calorimetry (DSC) confirmed the successful encapsulation of azithromycin in transethosomes. The formulations exhibited acceptable physical stability at 4 °C for six months. Ex vivo studies revealed a significantly higher deposition of azithromycin in the skin by both transethosome formulations than by the drug solution (p < 0.05), with low systemic absorption. Among the formulations, AZ 2 resulted in much deeper skin penetration, with deeper dermal and epidermal layer deposition (1.388 ± 0.242 µg/cm2) compared to AZ 1 (four-fold higher, p < 0.05) and to the control drug solution (12 times more, p < 0.05). Analysis using ATR-FTIR suggested that azithromycin-loaded transethosomes improve the drug penetration by increasing the lipid fluidity and extracting lipids from the stratum corneum. Moreover, the transethosomes loaded with azithromycin demonstrated enhanced antibacterial efficacy against Staphylococcus aureus, with minimum inhibitory concentration (MIC) values that were lower than those of the free drug solution.

Conclusion

The results highlight the promising potential of transethosomes as a novel topical drug delivery system for azithromycin that offers improved therapeutic effects against skin infections

Schlagwörter

Stichwörter der Autor:innen

Staphylococcus aureusantibacterial activityazithromycindermal deliveryskin penetrationtopical treatmenttransethosomesvesicular drug delivery

Autor:innen und Institutionen

  • Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
  • Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Zarqa University, Zarqa 13110, Jordan.
  • Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.

ORCID-Profile: Hadeia Mashaqbeh, Alaa A A Aljabali

Förderung

  • Deanship of Scientific Research and Postgraduate Studies at Yarmouk University, Jordan

Zitieren

APA

Rezigue, M., Mashaqbeh, H., Aljabali, A. A. A., Mansour, R. S., & Hamzeh, I. (2025). Development and Evaluation of Azithromycin-Loaded Transethosomes for Enhanced Dermal Delivery and Antibacterial Efficacy. Pharmaceutics, 17(4), 400. https://doi.org/10.3390/pharmaceutics17040400

Vancouver

Rezigue M, Mashaqbeh H, Aljabali AAA, Mansour RS, Hamzeh I. Development and Evaluation of Azithromycin-Loaded Transethosomes for Enhanced Dermal Delivery and Antibacterial Efficacy. Pharmaceutics. 2025;17(4):400. doi:10.3390/pharmaceutics17040400

BibTeX
@article{Rezigue2025,
  author = {Rezigue, Meriem and Mashaqbeh, Hadeia and Aljabali, Alaa A A and Mansour, Randa Sh and Hamzeh, Iyad},
  title = {Development and Evaluation of Azithromycin-Loaded Transethosomes for Enhanced Dermal Delivery and Antibacterial Efficacy},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {400},
  doi = {10.3390/pharmaceutics17040400}
}
Kostenlos starten →